PL366565A1 - Modulatory działania receptora jądrowego hormonalnego o budowie cyklicznej skondensowanej - Google Patents
Modulatory działania receptora jądrowego hormonalnego o budowie cyklicznej skondensowanejInfo
- Publication number
- PL366565A1 PL366565A1 PL01366565A PL36656501A PL366565A1 PL 366565 A1 PL366565 A1 PL 366565A1 PL 01366565 A PL01366565 A PL 01366565A PL 36656501 A PL36656501 A PL 36656501A PL 366565 A1 PL366565 A1 PL 366565A1
- Authority
- PL
- Poland
- Prior art keywords
- hormone receptor
- nuclear hormone
- fused cyclic
- receptor function
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21439200P | 2000-06-28 | 2000-06-28 | |
US28443801P | 2001-04-18 | 2001-04-18 | |
US28461701P | 2001-04-18 | 2001-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL366565A1 true PL366565A1 (pl) | 2005-02-07 |
Family
ID=27395986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL01366565A PL366565A1 (pl) | 2000-06-28 | 2001-06-20 | Modulatory działania receptora jądrowego hormonalnego o budowie cyklicznej skondensowanej |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20030014407A (pl) |
CN (1) | CN1443187A (pl) |
AR (1) | AR031709A1 (pl) |
CZ (1) | CZ20024250A3 (pl) |
IL (1) | IL152890A0 (pl) |
PE (1) | PE20030186A1 (pl) |
PL (1) | PL366565A1 (pl) |
TR (1) | TR200202702T2 (pl) |
UY (1) | UY26809A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8546451B2 (en) | 2005-11-28 | 2013-10-01 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US9409856B2 (en) | 2005-11-28 | 2016-08-09 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
EP1954670A4 (en) * | 2005-11-28 | 2011-04-27 | Gtx Inc | NUCLEAR RECEPTOR BINDING AGENTS |
CN102875556B (zh) * | 2011-07-12 | 2016-03-30 | 天津药明康德新药开发有限公司 | (4s)-1-取代-2,5-二氮杂双环[2,2,1]庚烷衍生物及制备方法 |
CN110184346A (zh) * | 2019-07-11 | 2019-08-30 | 德阳市人民医院 | 男性骨质疏松症的诊断标志物 |
-
2001
- 2001-06-20 IL IL15289001A patent/IL152890A0/xx unknown
- 2001-06-20 CN CN01811976A patent/CN1443187A/zh active Pending
- 2001-06-20 CZ CZ20024250A patent/CZ20024250A3/cs unknown
- 2001-06-20 KR KR1020027017857A patent/KR20030014407A/ko not_active Application Discontinuation
- 2001-06-20 TR TR2002/02702T patent/TR200202702T2/ unknown
- 2001-06-20 PL PL01366565A patent/PL366565A1/pl not_active Application Discontinuation
- 2001-06-28 AR ARP010103100A patent/AR031709A1/es unknown
- 2001-06-28 UY UY26809A patent/UY26809A1/es not_active Application Discontinuation
- 2001-08-23 PE PE2001000651A patent/PE20030186A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20030186A1 (es) | 2003-03-23 |
AR031709A1 (es) | 2003-10-01 |
UY26809A1 (es) | 2002-01-31 |
CZ20024250A3 (cs) | 2003-10-15 |
TR200202702T2 (tr) | 2004-12-21 |
KR20030014407A (ko) | 2003-02-17 |
CN1443187A (zh) | 2003-09-17 |
IL152890A0 (en) | 2003-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002359727A8 (en) | Fused cyclic modulators of nuclear hormone receptor function | |
MY138531A (en) | Fused heterocyclic succinmide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
TWI263640B (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
AU2002364082A8 (en) | Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function | |
WO2002000653A3 (en) | Fused cyclic compounds as modulators of nuclear hormone receptor function | |
WO2006002102A3 (en) | Spirocyclic compounds useful as modulators of nuclear hormone receptor function | |
MX9700223A (es) | Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida. | |
CA2366932A1 (en) | Cyclic protein tyrosine kinase inhibitors | |
MX9707021A (es) | Receptor de il-7. | |
EP1049459A4 (en) | ORAL LIQUID COMPOSITIONS | |
EP0991618A4 (en) | SELECTIVE ANALOGS OF THYROID HORMONES | |
MY136520A (en) | Novel compounds | |
GB9317104D0 (en) | Therapeutic heterocycles | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
PL366565A1 (pl) | Modulatory działania receptora jądrowego hormonalnego o budowie cyklicznej skondensowanej | |
EP1854798A3 (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
MXPA02012015A (es) | Ligandos de receptores para integrinas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |